BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22001954)

  • 1. ACE-inhibitor therapy at relatively high doses and risk of renal worsening in chronic heart failure.
    De Vecchis R; Di Biase G; Ariano C; Cioppa C; Giasi A; Ciccarelli A; Pucciarelli A; Cantatrione S
    Arq Bras Cardiol; 2011 Dec; 97(6):507-16. PubMed ID: 22001954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.
    Massie BM; Armstrong PW; Cleland JG; Horowitz JD; Packer M; Poole-Wilson PA; Rydén L
    Arch Intern Med; 2001 Jan; 161(2):165-71. PubMed ID: 11176729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
    Luzier AB; Forrest A; Adelman M; Hawari FI; Schentag JJ; Izzo JL
    Am J Cardiol; 1998 Aug; 82(4):465-9. PubMed ID: 9723634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Fröhlich H; Nelges C; Täger T; Schwenger V; Cebola R; Schnorbach J; Goode KM; Kazmi S; Katus HA; Cleland JG; Clark AL; Frankenstein L
    Am Heart J; 2016 Aug; 178():28-36. PubMed ID: 27502849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretics potentiate angiotensin converting enzyme inhibitor-induced acute renal failure.
    Mandal AK; Markert RJ; Saklayen MG; Mankus RA; Yokokawa K
    Clin Nephrol; 1994 Sep; 42(3):170-4. PubMed ID: 7994935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group.
    Nanas JN; Alexopoulos G; Anastasiou-Nana MI; Karidis K; Tirologos A; Zobolos S; Pirgakis V; Anthopoulos L; Sideris D; Stamatelopoulos SF; Moulopoulos SD
    J Am Coll Cardiol; 2000 Dec; 36(7):2090-5. PubMed ID: 11127445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisinopril in the treatment of congestive heart failure.
    Giles TD
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():83-7. PubMed ID: 2550647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure.
    Farquharson CA; Struthers AD
    J Am Coll Cardiol; 2002 Mar; 39(5):767-75. PubMed ID: 11869839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure.
    Levine TB; Levine AB; Keteyian SJ; Narins B
    Clin Cardiol; 1998 Dec; 21(12):899-904. PubMed ID: 9853182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of dose of angiotensin I-converting enzyme inhibitor on systolic blood pressure variability in heart failure: a substudy of the Assessment of Treatment with Lisinopril and Survival in heart failure (ATLAS) trial.
    Giles TD; Kerut EK; Roffidal LE; Jones R; Given MB; Hutchinson H; Tresznewsky O
    Blood Press Monit; 2001 Apr; 6(2):81-4. PubMed ID: 11433128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure.
    Cioffi G; Tarantini L; Pulignano G; Del Sindaco D; De Feo S; Opasich C; Dilenarda A; Stefenelli C; Furlanello F
    J Cardiovasc Med (Hagerstown); 2007 Jun; 8(6):419-27. PubMed ID: 17502758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.
    Greenbaum R; Zucchelli P; Caspi A; Nouriel H; Paz R; Sclarovsky S; O'Grady P; Yee KF; Liao WC; Mangold B
    Br J Clin Pharmacol; 2000 Jan; 49(1):23-31. PubMed ID: 10606834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.
    Packer M; Poole-Wilson PA; Armstrong PW; Cleland JG; Horowitz JD; Massie BM; Rydén L; Thygesen K; Uretsky BF
    Circulation; 1999 Dec; 100(23):2312-8. PubMed ID: 10587334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance to ACE inhibitors after cardiac surgery.
    Manché A; Galea J; Busuttil W
    Eur J Cardiothorac Surg; 1999 Jan; 15(1):55-60. PubMed ID: 10077374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound evaluation of the inferior vena cava collapsibility index in congestive heart failure patients treated with intravenous diuretics: new insights about its relationship with renal function: an observational study.
    De Vecchis R; Ariano C; Fusco A; Ciccarelli A; Cioppa C; Giasi A; Esposito C; Cantatrione S
    Anadolu Kardiyol Derg; 2012 Aug; 12(5):391-400. PubMed ID: 22564268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
    Osterziel KJ; Nagel F; Dietz R
    Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.